Core Scientific Secures Strategic \$1 Billion Financing Facility with Morgan Stanley

Key Points for Investors

• Core Scientific, Inc. (Nasdaq: CORZ) has completed the initial closing of a \$500 million loan facility provided by Morgan Stanley, with an option (accordion feature) to expand the facility up to \$1 billion.
• The loan facility is structured as a 364-day term loan and bears interest at SOFR + 2.50%.
• This financing significantly strengthens Core Scientific’s liquidity and enhances financial flexibility, positioning the company to accelerate project timelines and expand its high-density colocation and digital infrastructure services.
• The proceeds will be used for general corporate purposes related to data center asset development, including equipment purchases, pre-development costs, real property acquisition, and procurement of additional energy for data centers.

Strategic Implications and Potential Share Price Impact

The announcement is highly price sensitive and noteworthy for shareholders:

• The enhanced liquidity and expanded credit capacity provide Core Scientific with the ability to act decisively in the competitive digital infrastructure market, especially as demand for high-density colocation and artificial intelligence (AI) workloads increases.
• The company is actively transitioning its facilities—historically used for digital asset mining—to support AI-related workloads and next-generation colocation services. This strategic pivot is expected to rapidly increase revenues from high-density colocation, which could be a key growth driver and positively affect future earnings.
• Core Scientific maintains control over significant electrical power resources and plans to maximize the value of its mining equipment to third parties, while fulfilling obligations to suppliers and customers. This operational flexibility is crucial as the company repurposes its assets.
• Facilities are located across seven states: Alabama (1), Georgia (2), Kentucky (1), North Carolina (1), North Dakota (1), Oklahoma (1), and Texas (3). This geographical diversification supports operational resilience and scalability.

Forward-Looking Statements and Risks

The press release includes forward-looking statements regarding the use of the loan facility and its expected impact on liquidity and financial flexibility. Investors should be aware that:

• Actual results may differ materially from these statements due to risks, uncertainties, and assumptions—many of which are beyond the company’s control.
• Risks are detailed in Part I, Item 1A (“Risk Factors”) of Core Scientific’s Annual Report on Form 10-K for the year ended December 31, 2025.
• The company does not commit to updating its forward-looking statements, so shareholders should avoid placing undue reliance on them.

Investor Resources

For further information, investors can follow Core Scientific on LinkedIn, Twitter, and YouTube. Investor relations contact: [email protected].

Disclaimer

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All forward-looking statements are subject to risks and uncertainties. Investors are advised to review Core Scientific’s official filings and consult with financial advisors before making investment decisions.

View Core Scientific, Inc./tx Historical chart here